MEGADOSE METHYLPREDNISOLONE FOR EVANS SYNDROME

Author： Özsoylu Şinasi  

Publisher： Informa Healthcare

ISSN： 1521-0669

Source： Pediatric Hematology and Oncology, Vol.17, Iss.8, 2000-12, pp. : 725-726

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COMMENTS ON: Megadose Methylprednisolone for the Treatment of Patients with Evans Syndrome

By Ruggiero Antonio  

Pediatric Hematology and Oncology, Vol. 21, Iss. 8, 2004-12 ,pp. : 741-741

Informa Healthcare

Access to resources Recommend Favorite

MEGADOSE METHYLPREDNISOLONE FOR KASABACH-MERRITT SYNDROME

By Ozsoylu Sinasi  

Pediatric Hematology and Oncology, Vol. 16, Iss. 4, 1999-07 ,pp. : 373-374

Informa Healthcare

Access to resources Recommend Favorite

TREATMENT OF KASABACH–MERRITT SYNDROME BY MEGADOSE METHYLPREDNISOLONE

By Özsoylu Şinasi  

Pediatric Hematology and Oncology, Vol. 19, Iss. 5, 2002-07 ,pp. : 373-374

Informa Healthcare

Access to resources Recommend Favorite

MEGADOSE METHYPREDNISOLONE FOR THE TREATMENT OF PATIENTS WITH EVANS SYNDROME

By Özsoylu Fiinasi  

Pediatric Hematology and Oncology, Vol. 21, Iss. 8, 2004-12 ,pp. : 739-740

Informa Healthcare

Access to resources Recommend Favorite

MEGADOSE METHYLPREDNISOLONE FOR PROMYELOCYTIC LEUKEMIA

By Özsoylu Şinasi  

Pediatric Hematology and Oncology, Vol. 17, Iss. 8, 2000-12 ,pp. : 723-723

Informa Healthcare

Access to resources Recommend Favorite